Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David J. Hunter, Sc.D., M.B.,B.S.

Co-Author

This page shows the publications co-authored by David Hunter and Immaculata De Vivo.
Connection Strength

4.846
  1. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1152-6.
    View in: PubMed
    Score: 0.421
  2. The progesterone receptor Val660-->Leu polymorphism and breast cancer risk. Breast Cancer Res. 2004; 6(6):R636-9.
    View in: PubMed
    Score: 0.308
  3. Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 May; 11(5):489-92.
    View in: PubMed
    Score: 0.261
  4. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. J Med Genet. 2000 May; 37(5):336-41.
    View in: PubMed
    Score: 0.227
  5. GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. Hum Mol Genet. 2016 06 15; 25(12):2612-2620.
    View in: PubMed
    Score: 0.171
  6. Exome-wide association study of endometrial cancer in a multiethnic population. PLoS One. 2014; 9(5):e97045.
    View in: PubMed
    Score: 0.150
  7. Genome-wide association study of endometrial cancer in E2C2. Hum Genet. 2014 Feb; 133(2):211-24.
    View in: PubMed
    Score: 0.144
  8. Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women. PLoS One. 2012; 7(6):e37815.
    View in: PubMed
    Score: 0.131
  9. Genome-wide association study of relative telomere length. PLoS One. 2011 May 10; 6(5):e19635.
    View in: PubMed
    Score: 0.122
  10. Novel breast cancer risk alleles and endometrial cancer risk. Int J Cancer. 2008 Dec 15; 123(12):2961-4.
    View in: PubMed
    Score: 0.103
  11. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009 Feb; 129(2):415-21.
    View in: PubMed
    Score: 0.101
  12. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007 Apr; 16(4):815-9.
    View in: PubMed
    Score: 0.092
  13. The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies. Cancer Causes Control. 2007 Aug; 18(6):621-5.
    View in: PubMed
    Score: 0.092
  14. Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer. 2006 Mar 01; 118(5):1261-8.
    View in: PubMed
    Score: 0.085
  15. CYP19 (aromatase) haplotypes and endometrial cancer risk. Int J Cancer. 2005 Aug 20; 116(2):267-74.
    View in: PubMed
    Score: 0.082
  16. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol. 2005 Apr; 28(3):261-72.
    View in: PubMed
    Score: 0.080
  17. No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility. Pharmacogenetics. 2004 Dec; 14(12):851-6.
    View in: PubMed
    Score: 0.078
  18. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry. 2004 Sep; 161(9):1703-5.
    View in: PubMed
    Score: 0.077
  19. No association between MTHFR 677 C->T or 1298 A->C polymorphisms and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1088-9.
    View in: PubMed
    Score: 0.075
  20. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):520-4.
    View in: PubMed
    Score: 0.075
  21. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res. 2004 Feb 01; 64(3):1202-7.
    View in: PubMed
    Score: 0.074
  22. Genetic variations in XRCC2 and XRCC3 are not associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):330-1.
    View in: PubMed
    Score: 0.074
  23. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):213-9.
    View in: PubMed
    Score: 0.074
  24. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. Carcinogenesis. 2004 Apr; 25(4):559-65.
    View in: PubMed
    Score: 0.073
  25. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res. 2003 Dec 01; 63(23):8536-41.
    View in: PubMed
    Score: 0.073
  26. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis. 2004 Feb; 25(2):189-95.
    View in: PubMed
    Score: 0.072
  27. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003 Nov 15; 12(22):2923-9.
    View in: PubMed
    Score: 0.072
  28. Multiple displacement amplification prior to single nucleotide polymorphism genotyping in epidemiologic studies. Biotechnol Lett. 2003 Jul; 25(13):1031-6.
    View in: PubMed
    Score: 0.071
  29. No association between a stop codon polymorphism in RAD52 and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1138-9.
    View in: PubMed
    Score: 0.067
  30. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev. 2001 Jun; 10(6):711-4.
    View in: PubMed
    Score: 0.061
  31. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res. 2001 May 15; 61(10):3955-60.
    View in: PubMed
    Score: 0.061
  32. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. Int J Cancer. 2021 01 15; 148(2):307-319.
    View in: PubMed
    Score: 0.058
  33. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer. 2000 Jul 15; 87(2):204-10.
    View in: PubMed
    Score: 0.058
  34. Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018 08 09; 9(1):3166.
    View in: PubMed
    Score: 0.050
  35. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017 Jun; 49(6):834-841.
    View in: PubMed
    Score: 0.046
  36. A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts. PLoS One. 2017; 12(3):e0173997.
    View in: PubMed
    Score: 0.046
  37. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun. 2016 06 13; 7:11843.
    View in: PubMed
    Score: 0.043
  38. Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology. 2016 Aug; 151(2):351-363.e28.
    View in: PubMed
    Score: 0.043
  39. Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat Genet. 2016 Feb; 48(2):189-94.
    View in: PubMed
    Score: 0.042
  40. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet. 2016 Mar 15; 25(6):1203-14.
    View in: PubMed
    Score: 0.042
  41. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
    View in: PubMed
    Score: 0.041
  42. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet. 2015 Nov; 47(11):1294-1303.
    View in: PubMed
    Score: 0.041
  43. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97.
    View in: PubMed
    Score: 0.040
  44. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res. 2014 Oct 15; 74(20):5808-18.
    View in: PubMed
    Score: 0.039
  45. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature. 2014 Oct 02; 514(7520):92-97.
    View in: PubMed
    Score: 0.038
  46. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.038
  47. Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort. Circ Cardiovasc Genet. 2014 Jun; 7(3):287-95.
    View in: PubMed
    Score: 0.038
  48. Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis. 2014 Aug; 35(8):1737-44.
    View in: PubMed
    Score: 0.037
  49. Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ. 2014 Mar 19; 348:g1610.
    View in: PubMed
    Score: 0.037
  50. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014 Mar 01; 23(5):1387-98.
    View in: PubMed
    Score: 0.036
  51. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res. 2013 Apr 01; 73(7):2211-20.
    View in: PubMed
    Score: 0.035
  52. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet. 2012; 8(7):e1002805.
    View in: PubMed
    Score: 0.033
  53. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet. 2012 Apr 15; 21(8):1918-30.
    View in: PubMed
    Score: 0.032
  54. Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 2011 Nov 01; 71(21):6758-63.
    View in: PubMed
    Score: 0.031
  55. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet. 2011 Nov 01; 20(21):4282-9.
    View in: PubMed
    Score: 0.031
  56. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84.
    View in: PubMed
    Score: 0.029
  57. The association of telomere length and genetic variation in telomere biology genes. Hum Mutat. 2010 Sep; 31(9):1050-8.
    View in: PubMed
    Score: 0.029
  58. Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr. 2010 May; 91(5):1273-80.
    View in: PubMed
    Score: 0.028
  59. +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer. Int J Cancer. 2009 Oct 01; 125(7):1685-91.
    View in: PubMed
    Score: 0.027
  60. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. Int J Cancer. 2009 Feb 01; 124(3):729-33.
    View in: PubMed
    Score: 0.026
  61. CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Dig Dis Sci. 2008 May; 53(5):1417-21.
    View in: PubMed
    Score: 0.025
  62. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer. 2005 May 10; 114(6):996-1001.
    View in: PubMed
    Score: 0.020
  63. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging. 2005 Apr; 26(4):475-84.
    View in: PubMed
    Score: 0.020
  64. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003 Jan; 77(1):27-36.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.